-
IRadimed Corp (IRMD) PT Raised to $35 at Roth Capital
-
Iradimed Corp. (IRMD): Solid Quarter, PT To $21 at Roth
-
IRadimed Corp (IRMD) PT Raised to $21 at Roth Capital
-
Roth Capital Resumes IRadimed Corp (IRMD) at Buy
-
Roth Capital Upgrades IRadimed Corp (IRMD) to Buy
-
Roth Capital Downgrades IRadimed Corp (IRMD) to Neutral
-
Iradimed Corp. (IRMD) Closes $29.1M Secondary Offering of Common Stock
-
IRADIMED CORPORATION Announces Closing of $29.1 Million Secondary Offering of Common Stock and Exercise of Overallotment Option
-
Iradimed Corp. (IRMD) Prices 1.04M Common Secondary Offering at $24.25/Share
-
IRADIMED CORPORATION Announces Pricing of Secondary Offering of Common Stock
-
Iradimed Corp. (IRMD) CEO to Offer Stock
-
IRADIMED CORPORATION Announces Proposed Secondary Offering of Common Stock
-
Roth Capital Raises Price Target on Iradimed Corp. (IRMD) After traveling with Management
-
Roth Capital Starts IRadimed Corp (IRMD) at Buy

